close icon

Bristol-Myers: Elliott Wave Setup can Double the Price

Bristol-Myers Squibb is in the process of acquiring Celgene in a $74 billion dollar cash-and-stock deal including debt. The deal faced opposition from hedge funds Wellington Management and Starboard Value, but ultimately gained shareholder approval on April 12th.

Arbitrageurs, who aim to profit from the discrepancy between the market price and the deal closing price, seem to have shorted BMY stock as a hedge, in order to protect their returns. The stock is set to open at $45.64 today, down from $54.38 in early March. In reality, BMY stock has been under pressure since July 2016, when it reached an all-time high of $77.12 a share.

The acquisition is expected to close in Q3 2019. From then on, management will have to deal with shareholder dilution, debt reduction and the integration of Celgene into Bristol-Myers. Despite the high quality of Celgene’s business, risks for long-term BMY investors have increased significantly. A lot can go wrong, but the actual outcome – positive or negative – will remain unknown for some time.

Bristol-Myers, A Pattern Has Emerged

Fortunately, we can look at the situation from another angle. It looks like all the news around BMY stock in the last three years, all the earnings reports, drug successes and failures, analysts’ upgrades and downgrades led to the formation of a recognizable Elliott Wave pattern. Take a look at it on the daily price chart of Bristol-Myers Squibb below.

Bristol-Myers setting the stage for a 100% rally

The daily chart reveals that the entire decline from $77.12 can be seen as an A-B-C flat correction. Waves A and B are simple a-b-c zigzags, while wave C appears to be an ending diagonal.

Prior to this retracement, BMY stock was in an uptrend. According to the Wave theory, once a correction is over the larger trend resumes. If we apply this here, it makes sense to expect a bullish reversal as wave 5 of C is poised to complete the entire pattern soon.

Despite all the risks, the market seems ready to give the BMY-Celgene deal its vote of confidence. The anticipated rally is supposed to regain all the value lost since July 2016. If this count is correct, a revisit of $77 a share is quite possible. Once there, $90 will not be too far away.

Did you like this analysis? Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

GTX Stock May Recover, but Remains Under Pressure

With a market cap of just over $1B, Garrett Motion Inc. is still considered a small company. Founded less than two years ago in Rolle, Switzerland, the company provides electric-boosting technologies for light and commercial vehicle manufacturers. In September 2018, GTX stock started trading on the NYSE. It was hovering in the vicinity of $20…

Read More »

Lockheed Setting the Stage for an Unpleasant Surprise

Lockheed Martin has been one of the best companies to own during the last ten years. The Great Recession dragged the stock down to $57.41. Once again, the point of maximum pessimism turned out to be the best time to buy. Two days ago, LMT closed at a new all-time high of $370.38 a share.…

Read More »

CVI Stock Keeps the Elliott Wave Rally Alive

The first time we wrote about CVR Energy was in September 2016. CVI stock was hovering below $15 a share at the time, following a crash from as high as $72 in 2013. Despite the terrible three years the bulls had to suffer through, our Elliott Wave analysis of CVI stock ‘s weekly chart convinced…

Read More »

WD Stock Gets Vulnerable Near All-Time Highs

Walker & Dunlop Inc. provides financing services to owners of commercial real estate from its 29 offices in the U.S. Valued at just $1.6 billion, the company is a hardly a mainstream name. WD stock has an average daily volume of less than 170 thousand shares. Apparently that is still enough for Elliott Wave patterns…

Read More »

CHKP Stock Can Ruin a Buy-the-Dip Strategy

Check Point Software Technologies is among the global leaders in the field of cyber security. The company was founded in 1993 and is headquartered in Tel Aviv, Israel, but CHKP stock trades on the NASDAQ since 1996. CHKP went though the dot-com bubble and burst in 1999-2002. Its stock price didn’t fully recover from it…

Read More »

Can Facebook ‘s Privacy Concerns Fulfill this Setup?

Facebook ‘s privacy policies are under the microscope once again. Personal e-mails uncovered during an FTC investigation reveal Mark Zuckerberg knew of the company’s problematic privacy practices. Facebook stock still hasn’t been able to fully recover from the crash in the second half of 2018, which dragged the price from $218.62 down to $123.02. How…

Read More »

JPMorgan: Risk is High After 10 Years of Bull Market

Between March 2000 and March 2009, JPMorgan Chase & Co. investors saw their holdings’ value decline by almost 78% as the stock fell from over $67 to less than $15 a share. The next ten years, on the other hand, have been a wonder to behold. JPM stock rose like a phoenix from its ashes,…

Read More »

More analyses